18F-PSMA is primarily used for the detection and staging of BCR PC and has several clinical advantages over 68Ga-PMSA, including increased availability in-clinic, and a higher positron yield with lower positron energy, which improves the contrast and decreases the noise in the images generated [94,95]. This evidence concerns the gene FOLH1 and pachyonychia congenita.